{
  "id": [
    "32205186"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32205186"
  ],
  "pmcid": [
    "PMC7102591"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7102591"
      ]
    }
  ],
  "doi": [
    "10.1016/j.autrev.2020.102523"
  ],
  "title": [
    "COVID-19 infection and rheumatoid arthritis: Faraway, so close!"
  ],
  "authorString": [
    "Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Favalli EG"
          ],
          "firstName": [
            "Ennio Giulio"
          ],
          "lastName": [
            "Favalli"
          ],
          "initials": [
            "EG"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute, Milan, Italy. Electronic address: enniofavalli@me.com."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Ingegnoli F"
          ],
          "firstName": [
            "Francesca"
          ],
          "lastName": [
            "Ingegnoli"
          ],
          "initials": [
            "F"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute, Milan, Italy; Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Italy."
              ]
            }
          ]
        },
        {
          "fullName": [
            "De Lucia O"
          ],
          "firstName": [
            "Orazio"
          ],
          "lastName": [
            "De Lucia"
          ],
          "initials": [
            "O"
          ],
          "authorId": [
            {
              "_": "0000-0003-2304-6661",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute, Milan, Italy."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Cincinelli G"
          ],
          "firstName": [
            "Gilberto"
          ],
          "lastName": [
            "Cincinelli"
          ],
          "initials": [
            "G"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Italy."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Cimaz R"
          ],
          "firstName": [
            "Rolando"
          ],
          "lastName": [
            "Cimaz"
          ],
          "initials": [
            "R"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Italy; Division of Pediatric Rheumatology, ASST Gaetano Pini-CTO Institute, Milan, Italy."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Caporali R"
          ],
          "firstName": [
            "Roberto"
          ],
          "lastName": [
            "Caporali"
          ],
          "initials": [
            "R"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute, Milan, Italy; Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Italy."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0003-2304-6661",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "5"
      ],
      "volume": [
        "19"
      ],
      "journalIssueId": [
        "2944504"
      ],
      "dateOfPublication": [
        "2020 May"
      ],
      "monthOfPublication": [
        "5"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-05-01"
      ],
      "journal": [
        {
          "title": [
            "Autoimmunity reviews"
          ],
          "ISOAbbreviation": [
            "Autoimmun Rev"
          ],
          "medlineAbbreviation": [
            "Autoimmun Rev"
          ],
          "NLMid": [
            "101128967"
          ],
          "ISSN": [
            "1568-9972"
          ],
          "ESSN": [
            "1873-0183"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "102523"
  ],
  "abstractText": [
    "The outbreak of the new coronavirus infections COVID-19 in December 2019 in China has quickly become a global health emergency. Given the lack of specific anti-viral therapies, the current management of severe acute respiratory syndrome coronaviruses (SARS-CoV-2) is mainly supportive, even though several compounds are now under investigation for the treatment of this life-threatening disease. COVID-19 pandemic is certainly conditioning the treatment strategy of a complex disorder as rheumatoid arthritis (RA), whose infectious risk is increased compared to the general population because of an overall impairment of immune system typical of autoimmune diseases combined with the iatrogenic effect generated by corticosteroids and immunosuppressive drugs. However, the increasing knowledge about the pathophysiology of SARS-CoV-2 infection is leading to consider some anti-rheumatic drugs as potential treatment options for the management of COVID-19. In this review we will critically analyse the evidences on either positive or negative effect of drugs commonly used to treat RA in this particular scenario, in order to optimize the current approach to RA patients."
  ],
  "affiliation": [
    "Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute, Milan, Italy. Electronic address: enniofavalli@me.com."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CO"
                  ],
                  "qualifierName": [
                    "complications"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CO"
                  ],
                  "qualifierName": [
                    "complications"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Arthritis, Rheumatoid"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CO"
                  ],
                  "qualifierName": [
                    "complications"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antirheumatic Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Immunocompromised Host"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "China"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pandemics"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Betacoronavirus"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Rheumatoid arthritis",
        "Treatment",
        "Coronavirus",
        "Dmards",
        "Cytokine Release Syndrome",
        "Covid-19"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antirheumatic Agents"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/j.autrev.2020.102523"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7102591"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7102591?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "46"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-04-21"
  ],
  "dateOfCreation": [
    "2020-03-25"
  ],
  "firstIndexDate": [
    "2020-03-25"
  ],
  "fullTextReceivedDate": [
    "2020-04-02"
  ],
  "dateOfRevision": [
    "2020-04-21"
  ],
  "electronicPublicationDate": [
    "2020-03-20"
  ],
  "firstPublicationDate": [
    "2020-03-20"
  ]
}